title: Alanine racemase mutants of Burkholderia pseudomallei and Burkholderia mallei and use of alanine racemase as a non-antibiotic-based selectable marker.
abstract: Burkholderia pseudomallei and Burkholderia mallei are category B select agents and must be studied under BSL3 containment in the United States. They are typically resistant to multiple antibiotics, and the antibiotics used to treat B. pseudomallei or B. mallei infections may not be used as selective agents with the corresponding Burkholderia species. Here, we investigated alanine racemase deficient mutants of B. pseudomallei and B. mallei for development of non-antibiotic-based genetic selection methods and for attenuation of virulence. The genome of B. pseudomallei K96243 has two annotated alanine racemase genes (bpsl2179 and bpss0711), and B. mallei ATCC 23344 has one (bma1575). Each of these genes encodes a functional enzyme that can complement the alanine racemase deficiency of Escherichia coli strain ALA1. Herein, we show that B. pseudomallei with in-frame deletions in both bpsl2179 and bpss0711, or B. mallei with an in-frame deletion in bma1575, requires exogenous D-alanine for growth. Introduction of bpsl2179 on a multicopy plasmid into alanine racemase deficient variants of either Burkholderia species eliminated the requirement for D-alanine. During log phase growth without D-alanine, the viable counts of alanine racemase deficient mutants of B. pseudomallei and B. mallei decreased within 2 hours by about 1000-fold and 10-fold, respectively, and no viable bacteria were present at 24 hours. We constructed several genetic tools with bpsl2179 as a selectable genetic marker, and we used them without any antibiotic selection to construct an in-frame ΔflgK mutant in the alanine racemase deficient variant of B. pseudomallei K96243. In murine peritoneal macrophages, wild type B. mallei ATCC 23344 was killed much more rapidly than wild type B. pseudomallei K96243. In addition, the alanine racemase deficient mutant of B. pseudomallei K96243 exhibited attenuation versus its isogenic parental strain with respect to growth and survival in murine peritoneal macrophages.
authors: Department of Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
authors: Sheryl L W
authors: SL
authors: Zajdowicz
authors: Jessica
authors: J
authors: Jones-Carson
authors: Andres
authors: A
authors: Vazquez-Torres
authors: Michael G
authors: MG
authors: Jobling
authors: Ronald E
authors: RE
authors: Gill
authors: Randall K
authors: RK
authors: Holmes
mesh_terms: D000409:Alanine / Q000494:pharmacology; D000411:Alanine Racemase / Q000737:chemistry / Q000235:genetics*; D000595:Amino Acid Sequence; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D042726:Burkholderia mallei / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics / Q000648:ultrastructure; D016957:Burkholderia pseudomallei / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics / Q000648:ultrastructure; D017353:Gene Deletion; D005798:Genes, Bacterial / Q000235:genetics; D056426:Genetic Loci / Q000235:genetics; D005819:Genetic Markers; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000382:microbiology / Q000648:ultrastructure; D051379:Mice; D050296:Microbial Viability / Q000187:drug effects; D008969:Molecular Sequence Data; D009154:Mutation / Q000235:genetics*; D010504:Periodic Acid / Q000494:pharmacology; D010957:Plasmids / Q000235:genetics; D016133:Polymerase Chain Reaction; D015203:Reproducibility of Results; D016415:Sequence Alignment
chemical_list: D000900:Anti-Bacterial Agents; D005819:Genetic Markers; D010504:Periodic Acid; D000411:Alanine Racemase; D000409:Alanine